VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $11 | +37.5% | 1,887 | 0.0% | 0.00% | – |
| Q1 2024 | $8 | -61.9% | 1,887 | -61.6% | 0.00% | – |
| Q4 2023 | $21 | -12.5% | 4,910 | -10.3% | 0.00% | – |
| Q3 2023 | $24 | -84.1% | 5,471 | -76.1% | 0.00% | -100.0% |
| Q2 2023 | $151 | -5.6% | 22,922 | -2.7% | 0.00% | 0.0% |
| Q1 2023 | $160 | -14.4% | 23,560 | -7.0% | 0.00% | -50.0% |
| Q4 2022 | $187 | -99.9% | 25,342 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $250,000 | -9.1% | 25,342 | +0.5% | 0.00% | -33.3% |
| Q2 2022 | $275,000 | -1.4% | 25,216 | +2.1% | 0.00% | +50.0% |
| Q1 2022 | $279,000 | -66.1% | 24,696 | -52.8% | 0.00% | -33.3% |
| Q4 2021 | $822,000 | +79.9% | 52,342 | +96.2% | 0.00% | -25.0% |
| Q3 2021 | $457,000 | -21.6% | 26,680 | -1.6% | 0.00% | -20.0% |
| Q2 2021 | $583,000 | +253.3% | 27,102 | +168.8% | 0.01% | +66.7% |
| Q4 2019 | $165,000 | -22.9% | 10,084 | +22.9% | 0.00% | -50.0% |
| Q4 2018 | $214,000 | – | 8,207 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 728,000 | $10,425,000 | 5.01% |
| Signpost Capital Advisors, LP | 828,793 | $11,868,000 | 4.38% |
| Palo Alto Investors LP | 3,786,908 | $54,229,000 | 3.18% |
| RTW INVESTMENTS, LP | 500,000 | $7,160,000 | 2.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,139,787 | $59,282,000 | 2.13% |
| First Light Asset Management, LLC | 229,818 | $3,291,000 | 1.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,461,305 | $35,246,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 175,000 | $2,506,000 | 0.92% |
| WALL STREET ASSOCIATES | 655,800 | $9,391,000 | 0.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 368,390 | $5,275,000 | 0.90% |